1. ADDITION OF LENALIDOMIDE TO R‐CHOP (R2CHOP) IMPROVES OUTCOMES IN NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): FIRST REPORT OF ECOG‐ACRIN1412 A RANDOMIZED PHASE 2 US INTERGROUP STUDY OF R2CHOP VS R‐CHOP. (12th June 2019) Authors: Nowakowski, G.S.; Hong, F.; Scott, D.W.; Macon, R.; King, R.L.; Habermann, T.M.; Wagner‐Johnston, N.; Casulo, C.; Wade, J.L.; Nagargoje, G.G.; Reynolds, C.M.; Cohen, J.B.; Khan, N.; Amengual, J.; Richards, K.L.; Little, R.F.; Leonard, J.P.; Friedberg, J.W.; Kostakoglu, L.; Kahl, B.S. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. RISK‐ADAPTED THERAPY IN ADULTS WITH BURKITT LYMPHOMA: UPDATED RESULTS OF a MULTICENTER PROSPECTIVE PHASE II STUDY OF DA‐EPOCH‐R. (June 2017) Authors: Dunleavy, K.; Roschewski, M.; Abramson, J.S.; Link, B.; Parekh, S.; Jagadeesh, D.; Bierman, P.; Watson, P.R.; Peace, D.; Hanna, W.; Powell, B.; Melani, C.; Lucas, A.; Steinberg, S.M.; Kahl, B.; Friedberg, J.W.; Little, R.F.; Bartlett, N.L.; Fanale, M.A.; Noy, A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗